氨磺必利 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "氨磺必利" in Chinese language version.

refsWebsite

Global rank Chinese rank

32web.archive.org

1^st place

22doi.org

2^nd place

23^rd place

20nih.gov

4^th place

5^th place

9worldcat.org

5^th place

12^th place

2tga.gov.au

3,984^th place

1,603^rd place

2springer.com

274^th place

320^th place

1wiley.com

222^nd place

216^th place

1nature.com

234^th place

227^th place

1thelancet.com

2,393^rd place

1,199^th place

1medicinescomplete.com

low place

9,960^th place

1medind.nic.in

low place

1sciencedirect.com

149^th place

292^nd place

1elsevier.com

610^th place

388^th place

1benthamopen.com

low place

1ijbcp.com

low place

1medicines.org.uk

3,823^rd place

3,456^th place

1wikipedia.org

low place

1unc.edu

1,538^th place

1,766^th place

1lww.com

2,769^th place

1,362^nd place

1psychiatrictimes.com

9,815^th place

7,156^th place

benthamopen.com

Carolina, Hardoy Maria; Giovanni, Carta Mauro. Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder. Clinical Practice & Epidemiology in Mental Health. 2010-01-27, 6 (1): 1–3 [2018-10-24]. ISSN 1745-0179. PMID 20498696. doi:10.2174/1745017901006010001. （原始内容存档于2018-10-24）.

doi.org

Rosenzweig, P.; Canal, M.; Patat, A.; Bergougnan, L.; Zieleniuk, I.; Bianchetti, G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Human Psychopharmacology: Clinical and Experimental. 2002-01, 17 (1): 1–13 [2021-10-06]. ISSN 0885-6222. PMID 12404702. doi:10.1002/hup.320. （原始内容存档于2021-10-06）（英语）.
Caccia, S. Biotransformation of Post-Clozapine Antipsychotics Pharmacological Implications. Clinical Pharmacokinetics. May 2000, 38 (5): 393–414. PMID 10843459. doi:10.2165/00003088-200038050-00002.
Noble, Stuart; Benfield, Paul. Amisulpride: A Review of its Clinical Potential in Dysthymia. CNS Drugs. 1999, 12 (6): 471–483. ISSN 1172-7047. doi:10.2165/00023210-199912060-00005 （英语）.
Pani, L; Gessa, G L. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Molecular Psychiatry. 2002-03, 7 (3): 247–253 [2021-10-06]. ISSN 1359-4184. PMID 11920152. doi:10.1038/sj.mp.4001040. （原始内容存档于2021-12-27）（英语）.
Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013-09-14, 382 (9896): 951–962 [2021-10-06]. ISSN 0140-6736. doi:10.1016/S0140-6736(13)60733-3. （原始内容存档于2014-10-23）（英语）.
Komossa, K; Rummel-Kluge, C; Hunger, H; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI; Kissling, W; Leucht, S (January 2010). "Amisulpride versus other atypical antipsychotics for schizophrenia" （页面存档备份，存于互联网档案馆）. The Cochrane Database of Systematic Reviews (1): CD006624. doi:10.1002/14651858.CD006624.pub2. PMC 4164462 （页面存档备份，存于互联网档案馆）. PMID 20091599 （页面存档备份，存于互联网档案馆）.
Leucht, S; Corves, C; Arbter, D; Engel, RR; Li, C; Davis, JM (January 2009). "Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis". Lancet. 373 (9657): 31–41. doi:10.1016/S0140-6736(08)61764-X. PMID 19058842 （页面存档备份，存于互联网档案馆）.
Solanki, RK; Sing, P; Munshi, D (Oct–Dec 2009). "Current perspectives in the treatment of resistant schizophrenia". Indian Journal of Psychiatry. 51 (4): 254–60. doi:10.4103/0019-5545.58289. PMC 2802371. PMID 20048449 （页面存档备份，存于互联网档案馆）.
Mouaffak, F; Tranulis, C; Gourevitch, R; Poirier, MF; Douki, S; Olié, JP; Lôo, H; Gourion, D (2006). "Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia". Clinical Neuropharmacology. 29 (1): 28–33. doi:10.1097/00002826-200601000-00009. PMID 16518132 （页面存档备份，存于互联网档案馆）.
Nuss, P.; Hummer, M.; Tessier, C. (2007). "The use of amisulpride in the treatment of acute psychosis" （页面存档备份，存于互联网档案馆）. Therapeutics and Clinical Risk Management. 3 (1): 3–11. doi:10.2147/tcrm.2007.3.1.3. PMC 1936283 （页面存档备份，存于互联网档案馆）. PMID 18360610 （页面存档备份，存于互联网档案馆）.
Lecrubier, Y; Boyer, P; Turjanski, S; Rein, W. Amisulpride versus imipramine and placebo in dysthymia and major depression. Journal of Affective Disorders. 1997-04, 43 (2): 95–103 [2018-10-24]. ISSN 0165-0327. doi:10.1016/s0165-0327(96)00103-6. （原始内容存档于2018-10-24）.
Carolina, Hardoy Maria; Giovanni, Carta Mauro. Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder. Clinical Practice & Epidemiology in Mental Health. 2010-01-27, 6 (1): 1–3 [2018-10-24]. ISSN 1745-0179. PMID 20498696. doi:10.2174/1745017901006010001. （原始内容存档于2018-10-24）.
Kaul, Vijay; Dutta, Shakti B.; Beg, Mirza A.; Bawa, Shalu; Anjoom, Mohammed; Singh, Nand K.; Dutta, Srihari. Comparative evaluation of amisulpride and escitalopram on Hamilton anxiety rating scale among depression patients in a tertiary care teaching hospital in Nepal. International Journal of Basic & Clinical Pharmacology. 2017-01-21, 4 (2): 349–353 [2018-10-24]. ISSN 2279-0780. doi:10.5455/2319-2003.ijbcp20150438. （原始内容存档于2018-06-14）（英语）.
McKeage, K; Plosker, GL (2004). "Amisulpride: a review of its use in the management of schizophrenia". CNS Drugs. 18 (13): 933–956. doi:10.2165/00023210-200418130-00007. ISSN 1172-7047 （页面存档备份，存于互联网档案馆）. PMID 15521794 （页面存档备份，存于互联网档案馆）.
Natesan, S; Reckless, GE; Barlow, KB; Nobrega, JN; Kapur, S (October 2008). "Amisulpride the 'atypical' atypical antipsychotic — Comparison to haloperidol, risperidone and clozapine". Schizophrenia Research. 105 (1–3): 224–235. doi:10.1016/j.schres.2008.07.005. PMID 18710798 （页面存档备份，存于互联网档案馆）.
Isbister, GK; Balit, CR; Macleod, D; Duffull, SB (August 2010). "Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes". Journal of Clinical Psychopharmacology. 30 (4): 391–395. doi:10.1097/JCP.0b013e3181e5c14c. PMID 20531221 （页面存档备份，存于互联网档案馆）.
Joy, JP; Coulter, CV; Duffull, SB; Isbister, GK (August 2011). "Prediction of Torsade de Pointes From the QT Interval: Analysis of a Case Series of Amisulpride Overdoses". Clinical Pharmacology & Therapeutics. 90 (2): 243–245. doi:10.1038/clpt.2011.107. PMID 21716272 （页面存档备份，存于互联网档案馆）.
Levine, M; Ruha, AM (July 2012). "Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management". CNS Drugs. 26 (7): 601–611. doi:10.2165/11631640-000000000-00000. PMID 22668123 （页面存档备份，存于互联网档案馆）.
Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009). "Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo" （页面存档备份，存于互联网档案馆）. Psychopharmacology. 205 (1): 119–28. doi:10.1007/s00213-009-1521-8. PMC 2821721 （页面存档备份，存于互联网档案馆）. PMID 19337725 （页面存档备份，存于互联网档案馆）.
Maitre, M.; Ratomponirina, C.; Gobaille, S.; Hodé, Y.; Hechler, V. (Apr 1994). "Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics". European Journal of Pharmacology. 256 (2): 211–214. doi:10.1016/0014-2999(94)90248-8. PMID 7914168 （页面存档备份，存于互联网档案馆）.
Blomme, Audrey; Conraux, Laurence; Poirier, Philippe; Olivier, Anne; Koenig, Jean-Jacques; Sevrin, Mireille; Durant, François; George, Pascal (2000), "Amisulpride, Sultopride and Sulpiride: Comparison of Conformational and Physico-Chemical Properties" （页面存档备份，存于互联网档案馆）, Molecular Modeling and Prediction of Bioactivity, Springer US, pp. 404–405, doi:10.1007/978-1-4615-4141-7_97, ISBN 9781461368571, retrieved 2018-09-21
Lecrubier, Y.; et al. (2001). "Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia". Neuropsychobiology. 44 (1): 41–46. doi:10.1159/000054913. PMID 11408792 （页面存档备份，存于互联网档案馆）.

elsevier.com

linkinghub.elsevier.com

Lecrubier, Y; Boyer, P; Turjanski, S; Rein, W. Amisulpride versus imipramine and placebo in dysthymia and major depression. Journal of Affective Disorders. 1997-04, 43 (2): 95–103 [2018-10-24]. ISSN 0165-0327. doi:10.1016/s0165-0327(96)00103-6. （原始内容存档于2018-10-24）.

ijbcp.com

Kaul, Vijay; Dutta, Shakti B.; Beg, Mirza A.; Bawa, Shalu; Anjoom, Mohammed; Singh, Nand K.; Dutta, Srihari. Comparative evaluation of amisulpride and escitalopram on Hamilton anxiety rating scale among depression patients in a tertiary care teaching hospital in Nepal. International Journal of Basic & Clinical Pharmacology. 2017-01-21, 4 (2): 349–353 [2018-10-24]. ISSN 2279-0780. doi:10.5455/2319-2003.ijbcp20150438. （原始内容存档于2018-06-14）（英语）.

lww.com

journals.lww.com

Cassano, G. B.a; Jori, M. C.b. "Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study" （页面存档备份，存于互联网档案馆）. International Clinical Psychopharmacology: January 2002 - Volume 17 - Issue 1 - p 27-32

medicines.org.uk

Sandoz Limited Summary of Product Characteristics, archived from the original on 2014-08-17, retrieved 2014-08-17

medicinescomplete.com

Brayfield, A, ed. (June 2017). "Amisulpride: Martindale: The Complete Drug Reference" （页面存档备份，存于互联网档案馆）. MedicineComplete. Pharmaceutical Press. Retrieved 5 August 2017.

medind.nic.in

Vishal Chhabra, Manjeet Singh Bhatia. "Amisulpride: a Brief Review" （页面存档备份，存于互联网档案馆）(PDF) DELHI PSYCHIATRY JOURNAL Vol.10 No.2. OCTOBER 2007

nature.com

Pani, L; Gessa, G L. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Molecular Psychiatry. 2002-03, 7 (3): 247–253 [2021-10-06]. ISSN 1359-4184. PMID 11920152. doi:10.1038/sj.mp.4001040. （原始内容存档于2021-12-27）（英语）.

nih.gov

ncbi.nlm.nih.gov

Rosenzweig, P.; Canal, M.; Patat, A.; Bergougnan, L.; Zieleniuk, I.; Bianchetti, G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Human Psychopharmacology: Clinical and Experimental. 2002-01, 17 (1): 1–13 [2021-10-06]. ISSN 0885-6222. PMID 12404702. doi:10.1002/hup.320. （原始内容存档于2021-10-06）（英语）.
Caccia, S. Biotransformation of Post-Clozapine Antipsychotics Pharmacological Implications. Clinical Pharmacokinetics. May 2000, 38 (5): 393–414. PMID 10843459. doi:10.2165/00003088-200038050-00002.
Pani, L; Gessa, G L. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Molecular Psychiatry. 2002-03, 7 (3): 247–253 [2021-10-06]. ISSN 1359-4184. PMID 11920152. doi:10.1038/sj.mp.4001040. （原始内容存档于2021-12-27）（英语）.
Komossa, K; Rummel-Kluge, C; Hunger, H; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI; Kissling, W; Leucht, S (January 2010). "Amisulpride versus other atypical antipsychotics for schizophrenia" （页面存档备份，存于互联网档案馆）. The Cochrane Database of Systematic Reviews (1): CD006624. doi:10.1002/14651858.CD006624.pub2. PMC 4164462 （页面存档备份，存于互联网档案馆）. PMID 20091599 （页面存档备份，存于互联网档案馆）.
Leucht, S; Corves, C; Arbter, D; Engel, RR; Li, C; Davis, JM (January 2009). "Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis". Lancet. 373 (9657): 31–41. doi:10.1016/S0140-6736(08)61764-X. PMID 19058842 （页面存档备份，存于互联网档案馆）.
Solanki, RK; Sing, P; Munshi, D (Oct–Dec 2009). "Current perspectives in the treatment of resistant schizophrenia". Indian Journal of Psychiatry. 51 (4): 254–60. doi:10.4103/0019-5545.58289. PMC 2802371. PMID 20048449 （页面存档备份，存于互联网档案馆）.
Mouaffak, F; Tranulis, C; Gourevitch, R; Poirier, MF; Douki, S; Olié, JP; Lôo, H; Gourion, D (2006). "Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia". Clinical Neuropharmacology. 29 (1): 28–33. doi:10.1097/00002826-200601000-00009. PMID 16518132 （页面存档备份，存于互联网档案馆）.
Nuss, P.; Hummer, M.; Tessier, C. (2007). "The use of amisulpride in the treatment of acute psychosis" （页面存档备份，存于互联网档案馆）. Therapeutics and Clinical Risk Management. 3 (1): 3–11. doi:10.2147/tcrm.2007.3.1.3. PMC 1936283 （页面存档备份，存于互联网档案馆）. PMID 18360610 （页面存档备份，存于互联网档案馆）.
Ravizza L. "Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators" （页面存档备份，存于互联网档案馆）. Journal of Psychopharmacology. 13(3):248-54 · February 1999. PMID: 10512080 （页面存档备份，存于互联网档案馆）
Boyer P, Lecrubier Y, Stalla-Bourdillon A, Fleurot O: Amisulpride versus Amineptine and Placebo for the Treatment of Dysthymia （页面存档备份，存于互联网档案馆）. Neuropsychobiology 1999;39:25-32. doi: 10.1159/000026556 （页面存档备份，存于互联网档案馆）
Carolina, Hardoy Maria; Giovanni, Carta Mauro. Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder. Clinical Practice & Epidemiology in Mental Health. 2010-01-27, 6 (1): 1–3 [2018-10-24]. ISSN 1745-0179. PMID 20498696. doi:10.2174/1745017901006010001. （原始内容存档于2018-10-24）.
McKeage, K; Plosker, GL (2004). "Amisulpride: a review of its use in the management of schizophrenia". CNS Drugs. 18 (13): 933–956. doi:10.2165/00023210-200418130-00007. ISSN 1172-7047 （页面存档备份，存于互联网档案馆）. PMID 15521794 （页面存档备份，存于互联网档案馆）.
Natesan, S; Reckless, GE; Barlow, KB; Nobrega, JN; Kapur, S (October 2008). "Amisulpride the 'atypical' atypical antipsychotic — Comparison to haloperidol, risperidone and clozapine". Schizophrenia Research. 105 (1–3): 224–235. doi:10.1016/j.schres.2008.07.005. PMID 18710798 （页面存档备份，存于互联网档案馆）.
Isbister, GK; Balit, CR; Macleod, D; Duffull, SB (August 2010). "Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes". Journal of Clinical Psychopharmacology. 30 (4): 391–395. doi:10.1097/JCP.0b013e3181e5c14c. PMID 20531221 （页面存档备份，存于互联网档案馆）.
Joy, JP; Coulter, CV; Duffull, SB; Isbister, GK (August 2011). "Prediction of Torsade de Pointes From the QT Interval: Analysis of a Case Series of Amisulpride Overdoses". Clinical Pharmacology & Therapeutics. 90 (2): 243–245. doi:10.1038/clpt.2011.107. PMID 21716272 （页面存档备份，存于互联网档案馆）.
Levine, M; Ruha, AM (July 2012). "Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management". CNS Drugs. 26 (7): 601–611. doi:10.2165/11631640-000000000-00000. PMID 22668123 （页面存档备份，存于互联网档案馆）.
Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009). "Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo" （页面存档备份，存于互联网档案馆）. Psychopharmacology. 205 (1): 119–28. doi:10.1007/s00213-009-1521-8. PMC 2821721 （页面存档备份，存于互联网档案馆）. PMID 19337725 （页面存档备份，存于互联网档案馆）.
Maitre, M.; Ratomponirina, C.; Gobaille, S.; Hodé, Y.; Hechler, V. (Apr 1994). "Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics". European Journal of Pharmacology. 256 (2): 211–214. doi:10.1016/0014-2999(94)90248-8. PMID 7914168 （页面存档备份，存于互联网档案馆）.
Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997). "Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity". J. Pharmacol. Exp. Ther. 280(1): 83–97. PMID 8996185 （页面存档备份，存于互联网档案馆）.
Lecrubier, Y.; et al. (2001). "Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia". Neuropsychobiology. 44 (1): 41–46. doi:10.1159/000054913. PMID 11408792 （页面存档备份，存于互联网档案馆）.

psychiatrictimes.com

Kaplan, A. (2004). "Psychotropic Medications Around the World". Psychiatric Times. 21 (5).

sciencedirect.com

Smeraldi, E. "Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study" （页面存档备份，存于互联网档案馆）. Journal of Affective Disorders, Volume 48, Issue 1, 1998, Pages 47-56, ISSN 0165-0327 （页面存档备份，存于互联网档案馆）.

springer.com

link.springer.com

Noble, Stuart; Benfield, Paul. Amisulpride: A Review of its Clinical Potential in Dysthymia. CNS Drugs. 1999, 12 (6): 471–483. ISSN 1172-7047. doi:10.2165/00023210-199912060-00005 （英语）.
Blomme, Audrey; Conraux, Laurence; Poirier, Philippe; Olivier, Anne; Koenig, Jean-Jacques; Sevrin, Mireille; Durant, François; George, Pascal (2000), "Amisulpride, Sultopride and Sulpiride: Comparison of Conformational and Physico-Chemical Properties" （页面存档备份，存于互联网档案馆）, Molecular Modeling and Prediction of Bioactivity, Springer US, pp. 404–405, doi:10.1007/978-1-4615-4141-7_97, ISBN 9781461368571, retrieved 2018-09-21

tga.gov.au

ebs.tga.gov.au

PRODUCT INFORMATION SOLIAN® TABLETS and SOLUTION (PDF). TGA eBusiness Services. Sanofi-Aventis Australia Pty Ltd. 9 September 2013 [17 October 2013]. （原始内容存档于2019-12-31）.
"PRODUCT INFORMATION SOLIAN® TABLETS and SOLUTION" （页面存档备份，存于互联网档案馆） (PDF). TGA eBusiness Services. Sanofi-Aventis Australia Pty Ltd. 9 September 2013. Retrieved 17 October 2013.

thelancet.com

Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013-09-14, 382 (9896): 951–962 [2021-10-06]. ISSN 0140-6736. doi:10.1016/S0140-6736(13)60733-3. （原始内容存档于2014-10-23）（英语）.

unc.edu

pdsp.unc.edu

Roth, BL; Driscol, J. "PDSP K_i Database" （页面存档备份，存于互联网档案馆）. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.

web.archive.org

Rosenzweig, P.; Canal, M.; Patat, A.; Bergougnan, L.; Zieleniuk, I.; Bianchetti, G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Human Psychopharmacology: Clinical and Experimental. 2002-01, 17 (1): 1–13 [2021-10-06]. ISSN 0885-6222. PMID 12404702. doi:10.1002/hup.320. （原始内容存档于2021-10-06）（英语）.
PRODUCT INFORMATION SOLIAN® TABLETS and SOLUTION (PDF). TGA eBusiness Services. Sanofi-Aventis Australia Pty Ltd. 9 September 2013 [17 October 2013]. （原始内容存档于2019-12-31）.
Pani, L; Gessa, G L. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Molecular Psychiatry. 2002-03, 7 (3): 247–253 [2021-10-06]. ISSN 1359-4184. PMID 11920152. doi:10.1038/sj.mp.4001040. （原始内容存档于2021-12-27）（英语）.
Pharmaceutical Society of Australia. Australian medicines handbook.. Adelaide, S. Aust.: Australian Medicines Handbook. 2013 [2021-10-06]. ISBN 978-0-9805790-9-3. OCLC 826673635. （原始内容存档于2021-10-06）.
Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013-09-14, 382 (9896): 951–962 [2021-10-06]. ISSN 0140-6736. doi:10.1016/S0140-6736(13)60733-3. （原始内容存档于2014-10-23）（英语）.
Brayfield, A, ed. (June 2017). "Amisulpride: Martindale: The Complete Drug Reference" （页面存档备份，存于互联网档案馆）. MedicineComplete. Pharmaceutical Press. Retrieved 5 August 2017.
Komossa, K; Rummel-Kluge, C; Hunger, H; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI; Kissling, W; Leucht, S (January 2010). "Amisulpride versus other atypical antipsychotics for schizophrenia" （页面存档备份，存于互联网档案馆）. The Cochrane Database of Systematic Reviews (1): CD006624. doi:10.1002/14651858.CD006624.pub2. PMC 4164462 （页面存档备份，存于互联网档案馆）. PMID 20091599 （页面存档备份，存于互联网档案馆）.
Leucht, S; Corves, C; Arbter, D; Engel, RR; Li, C; Davis, JM (January 2009). "Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis". Lancet. 373 (9657): 31–41. doi:10.1016/S0140-6736(08)61764-X. PMID 19058842 （页面存档备份，存于互联网档案馆）.
Solanki, RK; Sing, P; Munshi, D (Oct–Dec 2009). "Current perspectives in the treatment of resistant schizophrenia". Indian Journal of Psychiatry. 51 (4): 254–60. doi:10.4103/0019-5545.58289. PMC 2802371. PMID 20048449 （页面存档备份，存于互联网档案馆）.
Mouaffak, F; Tranulis, C; Gourevitch, R; Poirier, MF; Douki, S; Olié, JP; Lôo, H; Gourion, D (2006). "Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia". Clinical Neuropharmacology. 29 (1): 28–33. doi:10.1097/00002826-200601000-00009. PMID 16518132 （页面存档备份，存于互联网档案馆）.
Nuss, P.; Hummer, M.; Tessier, C. (2007). "The use of amisulpride in the treatment of acute psychosis" （页面存档备份，存于互联网档案馆）. Therapeutics and Clinical Risk Management. 3 (1): 3–11. doi:10.2147/tcrm.2007.3.1.3. PMC 1936283 （页面存档备份，存于互联网档案馆）. PMID 18360610 （页面存档备份，存于互联网档案馆）.
Vishal Chhabra, Manjeet Singh Bhatia. "Amisulpride: a Brief Review" （页面存档备份，存于互联网档案馆）(PDF) DELHI PSYCHIATRY JOURNAL Vol.10 No.2. OCTOBER 2007
Ravizza L. "Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators" （页面存档备份，存于互联网档案馆）. Journal of Psychopharmacology. 13(3):248-54 · February 1999. PMID: 10512080 （页面存档备份，存于互联网档案馆）
Smeraldi, E. "Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study" （页面存档备份，存于互联网档案馆）. Journal of Affective Disorders, Volume 48, Issue 1, 1998, Pages 47-56, ISSN 0165-0327 （页面存档备份，存于互联网档案馆）.
Boyer P, Lecrubier Y, Stalla-Bourdillon A, Fleurot O: Amisulpride versus Amineptine and Placebo for the Treatment of Dysthymia （页面存档备份，存于互联网档案馆）. Neuropsychobiology 1999;39:25-32. doi: 10.1159/000026556 （页面存档备份，存于互联网档案馆）
Lecrubier, Y; Boyer, P; Turjanski, S; Rein, W. Amisulpride versus imipramine and placebo in dysthymia and major depression. Journal of Affective Disorders. 1997-04, 43 (2): 95–103 [2018-10-24]. ISSN 0165-0327. doi:10.1016/s0165-0327(96)00103-6. （原始内容存档于2018-10-24）.
Carolina, Hardoy Maria; Giovanni, Carta Mauro. Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder. Clinical Practice & Epidemiology in Mental Health. 2010-01-27, 6 (1): 1–3 [2018-10-24]. ISSN 1745-0179. PMID 20498696. doi:10.2174/1745017901006010001. （原始内容存档于2018-10-24）.
Kaul, Vijay; Dutta, Shakti B.; Beg, Mirza A.; Bawa, Shalu; Anjoom, Mohammed; Singh, Nand K.; Dutta, Srihari. Comparative evaluation of amisulpride and escitalopram on Hamilton anxiety rating scale among depression patients in a tertiary care teaching hospital in Nepal. International Journal of Basic & Clinical Pharmacology. 2017-01-21, 4 (2): 349–353 [2018-10-24]. ISSN 2279-0780. doi:10.5455/2319-2003.ijbcp20150438. （原始内容存档于2018-06-14）（英语）.
Sandoz Limited Summary of Product Characteristics, archived from the original on 2014-08-17, retrieved 2014-08-17
"PRODUCT INFORMATION SOLIAN® TABLETS and SOLUTION" （页面存档备份，存于互联网档案馆） (PDF). TGA eBusiness Services. Sanofi-Aventis Australia Pty Ltd. 9 September 2013. Retrieved 17 October 2013.
McKeage, K; Plosker, GL (2004). "Amisulpride: a review of its use in the management of schizophrenia". CNS Drugs. 18 (13): 933–956. doi:10.2165/00023210-200418130-00007. ISSN 1172-7047 （页面存档备份，存于互联网档案馆）. PMID 15521794 （页面存档备份，存于互联网档案馆）.
Natesan, S; Reckless, GE; Barlow, KB; Nobrega, JN; Kapur, S (October 2008). "Amisulpride the 'atypical' atypical antipsychotic — Comparison to haloperidol, risperidone and clozapine". Schizophrenia Research. 105 (1–3): 224–235. doi:10.1016/j.schres.2008.07.005. PMID 18710798 （页面存档备份，存于互联网档案馆）.
Isbister, GK; Balit, CR; Macleod, D; Duffull, SB (August 2010). "Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes". Journal of Clinical Psychopharmacology. 30 (4): 391–395. doi:10.1097/JCP.0b013e3181e5c14c. PMID 20531221 （页面存档备份，存于互联网档案馆）.
Joy, JP; Coulter, CV; Duffull, SB; Isbister, GK (August 2011). "Prediction of Torsade de Pointes From the QT Interval: Analysis of a Case Series of Amisulpride Overdoses". Clinical Pharmacology & Therapeutics. 90 (2): 243–245. doi:10.1038/clpt.2011.107. PMID 21716272 （页面存档备份，存于互联网档案馆）.
Levine, M; Ruha, AM (July 2012). "Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management". CNS Drugs. 26 (7): 601–611. doi:10.2165/11631640-000000000-00000. PMID 22668123 （页面存档备份，存于互联网档案馆）.
Roth, BL; Driscol, J. "PDSP K_i Database" （页面存档备份，存于互联网档案馆）. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.
Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009). "Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo" （页面存档备份，存于互联网档案馆）. Psychopharmacology. 205 (1): 119–28. doi:10.1007/s00213-009-1521-8. PMC 2821721 （页面存档备份，存于互联网档案馆）. PMID 19337725 （页面存档备份，存于互联网档案馆）.
Maitre, M.; Ratomponirina, C.; Gobaille, S.; Hodé, Y.; Hechler, V. (Apr 1994). "Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics". European Journal of Pharmacology. 256 (2): 211–214. doi:10.1016/0014-2999(94)90248-8. PMID 7914168 （页面存档备份，存于互联网档案馆）.
Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997). "Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity". J. Pharmacol. Exp. Ther. 280(1): 83–97. PMID 8996185 （页面存档备份，存于互联网档案馆）.
Cassano, G. B.a; Jori, M. C.b. "Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study" （页面存档备份，存于互联网档案馆）. International Clinical Psychopharmacology: January 2002 - Volume 17 - Issue 1 - p 27-32
Blomme, Audrey; Conraux, Laurence; Poirier, Philippe; Olivier, Anne; Koenig, Jean-Jacques; Sevrin, Mireille; Durant, François; George, Pascal (2000), "Amisulpride, Sultopride and Sulpiride: Comparison of Conformational and Physico-Chemical Properties" （页面存档备份，存于互联网档案馆）, Molecular Modeling and Prediction of Bioactivity, Springer US, pp. 404–405, doi:10.1007/978-1-4615-4141-7_97, ISBN 9781461368571, retrieved 2018-09-21
Lecrubier, Y.; et al. (2001). "Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia". Neuropsychobiology. 44 (1): 41–46. doi:10.1159/000054913. PMID 11408792 （页面存档备份，存于互联网档案馆）.

wikipedia.org

en.wikipedia.org

Brunton, L; Chabner, B; Knollman, B (2010). Goodman and Gilman's The Pharmacological Basis of Therapeutics（英语：Goodman and Gilman's The Pharmacological Basis of Therapeutics） (12th ed.). New York: McGraw-Hill Professional. ISBN 978-0-07-162442-8.

wiley.com

onlinelibrary.wiley.com

Rosenzweig, P.; Canal, M.; Patat, A.; Bergougnan, L.; Zieleniuk, I.; Bianchetti, G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Human Psychopharmacology: Clinical and Experimental. 2002-01, 17 (1): 1–13 [2021-10-06]. ISSN 0885-6222. PMID 12404702. doi:10.1002/hup.320. （原始内容存档于2021-10-06）（英语）.

worldcat.org

Rosenzweig, P.; Canal, M.; Patat, A.; Bergougnan, L.; Zieleniuk, I.; Bianchetti, G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Human Psychopharmacology: Clinical and Experimental. 2002-01, 17 (1): 1–13 [2021-10-06]. ISSN 0885-6222. PMID 12404702. doi:10.1002/hup.320. （原始内容存档于2021-10-06）（英语）.
Noble, Stuart; Benfield, Paul. Amisulpride: A Review of its Clinical Potential in Dysthymia. CNS Drugs. 1999, 12 (6): 471–483. ISSN 1172-7047. doi:10.2165/00023210-199912060-00005 （英语）.
Pani, L; Gessa, G L. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Molecular Psychiatry. 2002-03, 7 (3): 247–253 [2021-10-06]. ISSN 1359-4184. PMID 11920152. doi:10.1038/sj.mp.4001040. （原始内容存档于2021-12-27）（英语）.
Pharmaceutical Society of Australia. Australian medicines handbook.. Adelaide, S. Aust.: Australian Medicines Handbook. 2013 [2021-10-06]. ISBN 978-0-9805790-9-3. OCLC 826673635. （原始内容存档于2021-10-06）.
Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013-09-14, 382 (9896): 951–962 [2021-10-06]. ISSN 0140-6736. doi:10.1016/S0140-6736(13)60733-3. （原始内容存档于2014-10-23）（英语）.
Lecrubier, Y; Boyer, P; Turjanski, S; Rein, W. Amisulpride versus imipramine and placebo in dysthymia and major depression. Journal of Affective Disorders. 1997-04, 43 (2): 95–103 [2018-10-24]. ISSN 0165-0327. doi:10.1016/s0165-0327(96)00103-6. （原始内容存档于2018-10-24）.
Carolina, Hardoy Maria; Giovanni, Carta Mauro. Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder. Clinical Practice & Epidemiology in Mental Health. 2010-01-27, 6 (1): 1–3 [2018-10-24]. ISSN 1745-0179. PMID 20498696. doi:10.2174/1745017901006010001. （原始内容存档于2018-10-24）.
Kaul, Vijay; Dutta, Shakti B.; Beg, Mirza A.; Bawa, Shalu; Anjoom, Mohammed; Singh, Nand K.; Dutta, Srihari. Comparative evaluation of amisulpride and escitalopram on Hamilton anxiety rating scale among depression patients in a tertiary care teaching hospital in Nepal. International Journal of Basic & Clinical Pharmacology. 2017-01-21, 4 (2): 349–353 [2018-10-24]. ISSN 2279-0780. doi:10.5455/2319-2003.ijbcp20150438. （原始内容存档于2018-06-14）（英语）.
McKeage, K; Plosker, GL (2004). "Amisulpride: a review of its use in the management of schizophrenia". CNS Drugs. 18 (13): 933–956. doi:10.2165/00023210-200418130-00007. ISSN 1172-7047 （页面存档备份，存于互联网档案馆）. PMID 15521794 （页面存档备份，存于互联网档案馆）.